WITH THE TREND RISING AT AN ALARMING RATE. YEAH, AND BLAKE, THOSE NUMBERS RISING SO QUICKLY THAT NOW NISSANS ARE THE SECOND MOST COMMONLY STOLEN VEHICLE IN THE CITY. ACCORDING TO COURT RECORDS, IT’S ...
Asgard’s immunotherapy, AT-108, induces systemic, dose-dependent efficacy with broad tumor activity in preclinical studies ...
Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in ...
The immune cells are a key part of the body that keep humans healthy. But that also means when the cells age, the body grows ...
Researchers showed that an experimental therapy indirectly converted suppressive immune cells into tumor-fighting cells. This ...
St. Jude Children's Research Hospital scientists have discovered how tumors disable immune "gatekeeper" cells that alert the rest of the immune system to the presence of cancer—and how restoring their ...
New study reveals metabolic remodeling as an early event in diastolic dysfunction Restrictive cardiomyopathy (RCM) caused by ...
Asgard’s immunotherapy, AT-108, induces systemic, dose-dependent efficacy with broad tumor activity in preclinical studies and key biomarkers identifiedAT-108 combines the advantages of an off-the-she ...
Medical oncologist (ex AstraZeneca, MorphoSys, Autolus Therapeutics) joins to advance Asgard's lead asset AT-108 into Phase 1 clinical development -- AT-108 is a transformative immunotherapy that ...
In today's manufacturing environments, upgrading a robot fleet often means starting from scratch—not only replacing hardware, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results